Login
Mission
ABOUT US

Transforming healthcare through precision medicine.

Velsera’s vision is to be the discovery, evidence generation, and clinical delivery platform for precision medicine. We help doctors and drug hunters make better decisions about providing the right therapy to the right patients at the right time.  We have spent the last 10+ years’ developing industry leading clinical software, knowledge and perspectives on genetic disease - including oncology, rare and hereditary diseases.


Velsera was formed in January 2023 through the merger of three leading precision medicine companies – Perian Dx in the clinical diagnostics space, Seven Bridges in the life science analytics domain and UgenTec in the clinical laboratory automation industry. Today, Velsera employs 600 people across US, Europe and Asia, including over 150 employees with MD/PhD across our own in-house scientific, bioinformatic and clinical expert teams.

Our customer base includes some of the largest and most prestigious biopharma/biotech companies; government agencies and non-profits; clinical institutions and AMCs; diagnostic lab groups; we have partnerships with OEM lab instrument providers and also partner with diagnostic assay developers. The combination of our founding companies has created a unique capability and solution set to serve these customers across the diagnostic and drug development and commercialization life-cycle, including – (sub)population health, drug discovery, clinical development of new diagnostics and therapeutics, clinical delivery, lab management, RWD/E.

PURPOSE

Powering precision medicine.

Velsera connects healthcare and life sciences to reveal the true promise of precision medicine—a continuous flow of knowledge between researchers, scientists and clinicians around the world, creating insights that radically improve human health.

We power this ecosystem of insight with data made actionable by AI and technology solutions that accelerate R&D, democratize omics and provide bedside analytics to improve patient outcomes.

Stay in the loop with product and service updates as we create a new era of medicine powered by Velsera—the precision engine company.

See what's new
woman-ripple

Executive team.

Jamie Headshot

Jamie Littlejohns

Chief Executive Officer

Jamie joined Velsera in January 2024, having previously provided external support to Velsera and their founding business since early 2022. He has worked in healthcare and life sciences since 2010 and previously was a Partner at McKinsey & Company where he spent over a decade and led their Health & Life Science Investing Practice in Europe, specializing in supporting investor-backed health & life science tech businesses on their scale-up journeys.

Nathan-Baird

Nathan Baird

Chief Product Officer

Nate has deep experience in product portfolio strategy, financial analysis and next-generation sequencing product development, as well as an extensive academic research background in molecular genetics and genomics. Prior to joining Velsera, he worked at Illumina for more than eight years.

Purvesh-patel

Purvesh Patel

Chief Administrative Officer

Purvesh has worked in executive level legal, strategy and business development roles at leading global technology and healthcare companies, including Calyx, Oracle and Syneos Health. He was most recently general counsel and chief compliance officer at Calyx before joining Velsera. Purvesh also serves as Velsera's chief legal officer and corporate secretary. 

Jim Lee

Jim Lee

Chief Commercial Officer

Jim is a passionate commercial officer with extensive experience in the life sciences sector, dedicated to driving advancements in patient care. Adept leader in operations and revenue generation within the dynamic and competitive life sciences industry. He has worked in healthcare and life sciences since 2008 and was Vice President of Sales at Clarivate where he spent over a decade and led their Health & Life Science Commercial Group globally, specializing in scaling customer facing teams.

Patrick_John-1

John Patrick

Chief Technology Officer

JP brings extensive experience in product development, software engineering and secure cloud hosting to Velsera. Most recently, he was the EVP of engineering at TalentReef, and beforehand he was the SVP of product development and cloud hosting services at Bioclinica.

Verhoeven_Steven-1

Steven Verhoeven

Chief Operating Officer

Steven has strong operational experience in enterprise software organizations. Previously he was the CEO at UgenTec, where he developed the company into a global leader in molecular workflow automation. He also led informatics strategy and operations at Agilent Technologies and was COO at Cartagenia. 

Value loop

How we accelerate the value of omics.

When knowledge flows freely between the clinical realm and R&D, a network effect arises: research discoveries translate to diagnostics, and patient outcomes inform new breakthroughs.

This virtuous cycle drives what we call the value loop—iterative learning and technology-enabled solutions that support all points in the healthcare continuum.

loop-point-pink
Sample
Sample

Our technology manages and orchestrates the flow of patient samples using cutting-edge tracking and tracing to guard the quality of data and maximize its use for research and diagnostics.

loop-point-orange
Analyze
Analyze

We apply AI and machine learning software to automate the analysis of multiple testing modalities, producing results that are qualitative, accurate and amenable for clinical annotation and reporting.

loop-point-orange
Annotate
Annotate

We equip clinicians with annotation that combines multi-omic data, clinical analytics and treatment guidelines to reveal relevant information for diagnosis, therapy options and response prediction.

loop-point-pink
Report
Report

Our teams curate a continuously growing knowledge base that effectively democratizes omics, providing unparalleled access to data and clinical information for accurate and up-to-date reporting.

loop-point-purple
Aggregate
Aggregate

We aggregate clinical information and its underlying raw data to provide a multi-omic view that enhances data from clinical trials and research studies, leveraging insight from both sides of the loop.

loop-point-blue
Integrate
Integrate

Our broad expertise integrating diverse datasets provides the tools and services needed to make data work together, unlocking unprecedented insights that make joint discovery possible.

loop-point-blue
Explore
Explore

Our data and knowledge bases can be accessed independently or in conjunction with Velsera experts, with AI and machine learning performing intelligent, deep analyses that yield actionable insights.

loop-point-purple
Generalize
Generalize

These data-driven insights drive precision R&D, improve drug discovery and clinical trials as well as inform routine diagnostics— closing the loop and setting the standard for omics-based healthcare.

Sample
Sample

Our technology manages and orchestrates the flow of patient samples using cutting-edge tracking and tracing to guard the quality of data and maximize its use for research and diagnostics.

Analyze
Analyze

We apply AI and machine learning software to automate the analysis of multiple testing modalities, producing results that are qualitative, accurate and amenable for clinical annotation and reporting.

Annotate
Annotate

We equip clinicians with annotation that combines multi-omic data, clinical analytics and treatment guidelines to reveal relevant information for diagnosis, therapy options and response prediction.

Report
Report

Our teams curate a continuously growing knowledge base that effectively democratizes omics, providing unparalleled access to data and clinical information for accurate and up-to-date reporting.

Aggregate
Aggregate

We aggregate clinical information and its underlying raw data to provide a multi-omic view that enhances data from clinical trials and research studies, leveraging insight from both sides of the loop.

Integrate
Integrate

Our broad expertise integrating diverse datasets provides the tools and services needed to make data work together, unlocking unprecedented insights that make joint discovery possible.

Explore
Explore

Our data and knowledge bases can be accessed independently or in conjunction with Velsera experts, with AI and machine learning performing intelligent, deep analyses that yield actionable insights.

Generalize
Generalize

These data-driven insights drive precision R&D, improve drug discovery and clinical trials as well as inform routine diagnostics— closing the loop and setting the standard for omics-based healthcare.

Working at Velsera.

Velsera offers a compelling, flexible work environment with a team of diverse mission-driven employees from around the globe. If you have an interest working for an organization with great values that is truly making a difference within science and healthcare, you have come to the right place!  

learn more
Image

Learn more.

Our team is here to help -- whether you're interested in scheduling a demo, have a few questions or wish to share feedback.

We look forward to connecting with you.

Contact Us
Image-Jun-16-2023-11-39-24-7553-AM